Celgene

NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019

CELG Articles

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target,...
The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Some of the S&P 500's top gainers so far in 2019 have been companies that might seem rather surprising because they aren't ones that the investing community normally would be stepping all over...
The top analyst upgrades, downgrades and initiations seen on Friday included Bed Bath & Beyond, Celgene, Dow, Fannie Mae, Intel, Lennar, Snap, UGI, Viacom and WEX.
The top analyst upgrades, downgrades and initiations seen on Monday included Amazon.com, CarMax, Celgene, Chevron, Exxon Mobil, Lyft, FedEx, Peabody Energy, UPS and Wells Fargo.
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in...
The top analyst upgrades, downgrades and initiations seen on Friday included Alibaba, Amazon.com, AVEO Pharmaceuticals, Baker Hughes, Celgene, DowDuPont, Facebook, General Electric, Goldman Sachs and...